Keylika

Biopharmaceutical company focused on drug discovery and drug delivery, employing AI-enabled de novo drug design and nanotechnology-based transdermal delivery technologies to generate breakthrough therapies.

VisitClaim or join

Founded: Not disclosed
Headquarters: Not disclosed
Company size: 1–10
Products tracked: 3

Products by Keylika

3 products

NistuFeTransdermal iron patch described as the world's first Rx skin patch to treat iron deficiency anemia (IDA), enabling direct absorption of proprietary iron into blood circulation...0.00 reviewsDrug Discovery & Biotech

KYLK01New molecular entity (NME), a small molecule under 500 Da.0.00 reviewsDrug Discovery & Biotech

Platform synthesis technology for mixed ligand metal complexesPlatform synthesis technology for generating organometallic drugs for treating a wide range of therapeutic conditions including hematology, pain and inflammation, metabolic diso...0.00 reviewsDrug Discovery & Biotech

Pricing for Keylika

Contact sales

Contact Keylika for current plans, volume pricing, and enterprise terms.

Trust profile

Security and compliance

No compliance claims have been published for this company.